Athera Biotechnologies And Dyax Announce A Collaboration To Discover And Develop Antibodies For Cardiovascular Inflammation
October 3rd, 2008 by 
admin Athera Biotechnologies AB and Dyax Corp. (NASDAQ:DYAX) declared that they hit entered into a cooperation to conceive and to amend therapeutic products for the hindrance or communication of cardiovascular inflammatory diseases. The cooperation follows the past business of impact by Athera technological founders, Professors Frostegard and de Faire of the Karolinska Institutet.
Posted in Cardiology | 